You are here

Home

Medical - global

Primary tabs

Sat, 2013-06-22 21:44 — Gina Angiola
The medical working group is focused on issues that affect delivery of medical care to those in need

The medical working group seeks to address issues affecting delivery of medical care to those in need.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Dr Ojia Adamolekun LadyCath mike kraft
Subscribe to group

Email address for group

medical-global@m.resiliencesystem.org

COVID booster cuts severe COVID risk by a third in patients with weak immune systems--study

Thu, 2024-03-28 17:07 — mike kraft
Study: COVID booster cuts severe COVID risk by a third in patients with weak immune systems One dose of the updated, single-strain COVID-19 vaccine introduced last fall is 38% effective against hospitalization in the 7 to 59 days after receipt and 34% effective at 60 to 119 days in adults with weakened immune systems, yet uptake in this group is low, estimates a study published today in Morbidity and Mortality Weekly Report. CIDRAP

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Severity of infection and high blood presure lnked to long Covid--Swedish study

Thu, 2024-03-28 10:16 — mike kraft
Swedish study suggests link between long COVID and severity of illness Of those who had long COVID, 61% had been hospitalized after contracting the virus. CIDRAP

... high blood pressure may be a risk factor for developing the chronic condition. The study is published in BMJ Public Health.

...

Country / Region Tags: 
Global
Sweden
General Topic Tags: 
COVID-19
Symptoms
Data
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Recent studies suggest staying up-to-date on COVID shots helps protect high-risk groups from severe illness

Thu, 2024-03-28 10:06 — mike kraft
Do you need a spring COVID-19 vaccine? Research backs extra round for high-risk groups | CBC News Various Canadian provinces are rolling out spring COVID-19 vaccination campaigns, allowing higher-risk individuals to get an extra dose. CBC

New guidelines suggest certain high-risk groups could benefit from having another dose of a COVID-19 vaccine this spring — and more frequent shots in general — while the broader population could be entering once-a-year territory, much like an annual flu shot.

Medical experts told CBC News that falling behind on the latest shots can come with health risks, particularly for individuals who are older or immunocompromised.

Country / Region Tags: 
Canada
Global
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Government
Health
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Global COVID reinfection rate less than 1%, depending on variant, country, time --China Meta-analysis

Wed, 2024-03-27 17:49 — mike kraft
Meta-analysis: Global COVID reinfection rate less than 1%, depending on variant, country, time The results suggest that waning SARS-CoV-2 immunity levels over time can lead to reinfections and a new pandemic wave, the authors say. CIDRAP
Country / Region Tags: 
China
Global
General Topic Tags: 
COVID-19
Contagion
Symptoms
Data
Disease
Medical Testing
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Scientists study evolution of COVID in an effort to head off a resurgence

Wed, 2024-03-27 14:16 — mike kraft

Rat droppings from New York City. Poop from dog parks in Wisconsin. Human waste from a Missouri hospital. These are some of the materials that are readying us for the next chapter of the coronavirus saga.

More than four years into the pandemic, the virus has loosened its hold on most people’s bodies and minds. But a new variant better able to dodge our immune defenses may yet appear, derailing a hard-won return to normalcy.

Scientists around the country are watching for the first signs.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Contagion
Symptoms
Disease Prevention
Health
Medical Personnel
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Children with COVID but asymptomatic play key role in household spread --study

Tue, 2024-03-26 20:12 — mike kraft
Study: Kids with COVID but no symptoms play key role in household spread A study today in Clinical Infectious Diseases conducted across 12 tertiary care pediatric hospitals in Canada and the United States shows that asymptomatic children with COVID-19, especially preschoolers, contribute significantly to household transmission. CIDRAP

...

The researchers discovered that 10.6% of exposed household contacts developed symptomatic illness within 14 days of exposure to asymptomatic test-positive children, a rate higher than expected.

...

Country / Region Tags: 
Canada
Global
United States
General Topic Tags: 
COVID-19
Contagion
Children
Disease Prevention
Health
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Moderna says new Covid vaccine showed stronger immune response than current version --study

Tue, 2024-03-26 20:06 — mike kraft
Moderna says new Covid vaccine showed stronger immune response than current shot in study Moderna's new shot offers the potential of a longer shelf life and is one component of its combination vaccine targeting Covid and the flu. Annika Kim Constantino CNBC

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Health
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

U.S. FDA approves COVID preventive Pemgarda for immunocompromised persons

Tue, 2024-03-26 10:08 — mike kraft

 

FDA OKs Invivyd's COVID preventive Pemgarda for emergency use The pre-exposure treatment is indicated for adolescents and adults with moderate-to-severe immunocompromising conditions. CIDRAP

The Food and Drug Administration (FDA) on March 22 granted emergency use authorization (EUA) for Invivyd's monoclonal antibody to prevent COVID-19 in immunocompromised patients, which fills a gap following the withdrawal of Evusheld in January 2023.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Treatments
Disease Prevention
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Millions at risk from cholera due to shortages of watern vaccines--WHO

Fri, 2024-03-22 19:08 — mike kraft
Millions at risk from cholera due to lack of clean water, soap and toilets, and shortage of cholera vaccine Immediate action is needed to stem an unprecedented multi-year upsurge in cholera cases worldwide, according to the International Coordinating Group (ICG) on Vaccine Provision.
Country / Region Tags: 
Africa
Global
Latin America
United Nations
General Topic Tags: 
Disease
Disease Prevention
Health
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Climate change increasing infectious disease threats, physicians caution

Fri, 2024-03-22 17:49 — mike kraft
Climate change unleashing torrent of infectious disease threats, physicians caution The shorter and milder winters, warming oceans, altered precipitation patterns, and extreme weather of climate change are fueling the spread of infectious diseases, experts warn today in JAMA. CIDRAP

...

Country / Region Tags: 
Global
General Topic Tags: 
Contagion
Disease
Health
Pandemics
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis

Pages

howdy folks
Page loaded in 1.688 seconds.